These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 13876240)
1. Effect of alpha-methyl DOPA in severe and malignant hypertension. CANNON PJ; WHITLOCK RT; MORRIS RC; ANGERS M; LARAGH JH JAMA; 1962 Mar; 179():673-81. PubMed ID: 13876240 [No Abstract] [Full Text] [Related]
2. Alpha methyl dopa in the treatment of hypertension. DOYLE A; TREVAKS G Med J Aust; 1962 Jul; 49(2)():55-6. PubMed ID: 13887654 [No Abstract] [Full Text] [Related]
3. [Value of alpha-methyl-dopa for the treatment of chronic hypertension]. ARNOLD OH Dtsch Med Wochenschr; 1962 Apr; 87():844-8. PubMed ID: 13862447 [No Abstract] [Full Text] [Related]
4. Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension. GILLESPIE L; OATES JA; CROUT JR; SJOERDSMA A Circulation; 1962 Feb; 25():281-91. PubMed ID: 13898638 [No Abstract] [Full Text] [Related]
5. [Preliminary report on the clinical effectiveness of 1-alpha-methyl-DOPA (Aldomet) in the treatment of hypertension]. FELLINGER K; GRABNER G; KRYGICZ H Wien Z Inn Med; 1961 Dec; 42():527-30. PubMed ID: 13892223 [No Abstract] [Full Text] [Related]
6. [alpha-Methyl-DOPA. Therapeutic experiences in hypertension and biochemical research on its mode of action]. SCHAUB F; NAGER F; SCHAER H; ZIEGLER W; LICHTLEN P Schweiz Med Wochenschr; 1962 May; 92():620-8. PubMed ID: 14498080 [No Abstract] [Full Text] [Related]
7. Methyldopa in the treatment of hypertension. BAYLISS RI; HARVEY-SMITH EA Lancet; 1962 Apr; 1(7233):763-8. PubMed ID: 13866047 [No Abstract] [Full Text] [Related]
8. Methyldopa in hypertension. Clinical and pharmacological studies. DOLLERY CT; HARINGTON M Lancet; 1962 Apr; 1(7233):759-63. PubMed ID: 13887051 [No Abstract] [Full Text] [Related]
9. Clinical trial of a new hypotensive drug, methyldopa ("aldomet"). BAUMGARTEN A Med J Aust; 1962 Jul; 49(2)():52-5. PubMed ID: 13865946 [No Abstract] [Full Text] [Related]
10. Pharmacodynamics and clinical use of guanethidine, bretylium and methyldopa. KIRKENDALL WM; WILSON WR Am J Cardiol; 1962 Jan; 9():107-15. PubMed ID: 14456308 [No Abstract] [Full Text] [Related]
11. Pharmacodynamic effects and clinical use of alpha methyldopa in the treatment of essential hypertension. ONESTI G; BREST AN; NOVACK P; MOYER JH Am J Cardiol; 1962 Jun; 9():863-7. PubMed ID: 14482028 [No Abstract] [Full Text] [Related]
12. [Methyl-dopa (Aldomet), a new principle in the treatment of high blood pressure]. MATHISEN HS Tidsskr Nor Laegeforen; 1962 Mar; 82():353-5. PubMed ID: 14471146 [No Abstract] [Full Text] [Related]
13. [The effect of intravenously administered DOPA on the blood pressure in pretreated alpha-methyl-DOPA hypertensives. Studies on the blood pressure-lowering mechanism of alpha-methyl-DOPA]. SCHAER H; ZIEGLER WH Klin Wochenschr; 1962 Sep; 40():959-62. PubMed ID: 13976633 [No Abstract] [Full Text] [Related]
14. Effect of alpha-methyl-3,4-dihydroxyphenylalanine (methyldopa), reserpine and related agents on some vascular responses in the dog. STONE CA; ROSS CA; WENGER HC; LUDDEN CT; BLESSING JA; TOTARO JA; PORTER CC J Pharmacol Exp Ther; 1962 Apr; 136():80-8. PubMed ID: 13917453 [No Abstract] [Full Text] [Related]
15. In-vivo decarboxylation of alpha-methyl DOPA and alpha-methyl metatyrosine. CARLSSON A; LINDQVIST M Acta Physiol Scand; 1962 Jan; 54():87-94. PubMed ID: 13876658 [No Abstract] [Full Text] [Related]
16. Metabolic studies in carcinoid syndrome: observations on use of alpha-methyl DOPA, isonicotinic acid hydrazide and selective tryptophan deficiency. DAVIS RB; ALEXANDER CS; ADICOFF A Metabolism; 1961 Dec; 10():1035-44. PubMed ID: 13883956 [No Abstract] [Full Text] [Related]
17. Serotonin synthesis in carcinoid patients. Its inhibition by alpha-methyl-dopa, with measurement of associated increases in urinary 5-hydroxytryptophan. SJOERDSMA A; OATES JA; ZALTZMAN P; UDENFRIEND S N Engl J Med; 1960 Sep; 263():585-8. PubMed ID: 13831424 [No Abstract] [Full Text] [Related]
18. Spurious elevation of urinary catecholamines during therapy with alpha-methyl-dopa. A diagnostic pitfall. GIFFORD RW; TWEED DC JAMA; 1962 Oct; 182():493-5. PubMed ID: 13947776 [No Abstract] [Full Text] [Related]